Trial intelligence / Profile preview

Feasibility trials of topiramate, modafinil, or sustained-release dexamphetamine for crack-cocaine dependence in the Netherlands

2009-010584-16Phase 2Completed

Sponsor
ZonMw
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of topiramate, modafinil and dextroamphetamine in cocaine use disorder (CUD) and stimulant use disorder (SUD) (6 arms), sponsored by ZonMw. Primary endpoints: Acceptance of assigned medication treatment and Treatment retention. Started Dec 2010; status: completed.

02

Drugs

topiramatemodafinildextroamphetamine
03

Conditions

cocaine use disorder (CUD)stimulant use disorder (SUD)

Beyond the preview

Go deeper on 2009-010584-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010584-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call